Metastatic Liver Tumors
Diagnosis of Liver Disease, Second Edition, Page: 269-275
2019
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Book Chapter Description
Metastatic tumors are the most common type of malignancy in the liver, far exceeding primary tumors of the liver. The distinction between a primary tumor and a metastatic tumor in the liver has both therapeutic and prognostic significance. Knowledge of the primary tumor site and its morphology, if available, is important in evaluating and comparing it to its metastasis. Among tumor types, adenocarcinoma, neuroendocrine tumor, and lymphoma are the most common. Common primary sites include the colon (adenocarcinoma), pancreas (adenocarcinoma and pancreatic neuroendocrine tumor), stomach and small intestine (adenocarcinoma, neuroendocrine and gastrointestinal stromal tumor), lung (adenocarcinoma, small-cell and large-cell neuroendocrine carcinoma, and squamous cell carcinoma), breast, skin (melanoma), and kidney (renal cell carcinoma).
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85150150756&origin=inward; http://dx.doi.org/10.1007/978-981-13-6806-6_18; http://link.springer.com/10.1007/978-981-13-6806-6_18; http://link.springer.com/content/pdf/10.1007/978-981-13-6806-6_18; https://doi.org/10.1007%2F978-981-13-6806-6_18; https://dx.doi.org/10.1007/978-981-13-6806-6_18; https://link.springer.com/chapter/10.1007/978-981-13-6806-6_18
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know